Ligand Pharmaceuticals - Biopharma's Technology and Capital …
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the …
Ligand Pharmaceuticals Incorporated - Investor Relations
Nov 7, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of …
Ligand Pharmaceuticals Incorporated - Stock Info
Dec 11, 2023 · All 3m NASDAQ:LGND News Releases Oct 6 Oct 13 Oct 20 Oct 27 Nov 3 Nov 10 Nov 17 Nov 24 Dec 1 Dec 8 Dec 15 Dec 29 2021 2022 2023 2024 2025 2026 168 180 192 …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing …
Royalty Portfolio - Ligand Pharmaceuticals
Today, Ligand manages one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with more than 90 partnered commercial and development-stage …
About Us - Ligand Pharmaceuticals
Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs …
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel …
Apr 17, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing …
News & Events - Press Releases - Ligand Pharmaceuticals
Oct 30, 2025 · Download , Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients, October 9, 2025, (opens …
Ligand Pharmaceuticals Incorporated - Ligand Reports Third …
Nov 6, 2025 · For more information, please visit www.ligand.com. Follow Ligand on X and LinkedIn. We use our investor relations website and X as a means of disclosing material non …
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 27, 2025 · Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of …